Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215

Showing 76-100 of 215 citing articles:

Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital
Maura C Dodge, Lei Ye, Elizabeth R. Duffy, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 7
A SARS-CoV-2: Companion Animal Transmission and Variants Classification
Rachana Pandit, Qiana L. Matthews
Pathogens (2023) Vol. 12, Iss. 6, pp. 775-775
Open Access | Times Cited: 7
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein
Mariem Ghoula, Audrey Deyawe Kongmeneck, Rita Eid, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 40, pp. 8586-8602
Open Access | Times Cited: 7
One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the vaccine in civil circulation in Moscow
Inna V. Dolzhikova, Vladimir А. Gushchin, Dmitry V. Shcheblyakov, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 16
Designing for COVID-2x: Reflecting on Future-Proofing Human Habitation for the Inevitable Next Pandemic
Dirk Spennemann
Buildings (2022) Vol. 12, Iss. 7, pp. 976-976
Open Access | Times Cited: 11
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals
Anna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105949-105949
Open Access | Times Cited: 6
An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines
Han Cao, Shengran Yang, Yunfei Wang, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1261-1261
Open Access | Times Cited: 14
What We Are Learning from COVID-19 for Respiratory Protection: Contemporary and Emerging Issues
Rui Li, Mingjie Zhang, Yulin Wu, et al.
Polymers (2021) Vol. 13, Iss. 23, pp. 4165-4165
Open Access | Times Cited: 14
Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach
Jenifer Mallavarpu Ambrose, Malathi Kullappan, Shankargouda Patil, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1773-1773
Open Access | Times Cited: 10
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant
Olaf‐Oliver Wolz, Sarah-Katharina Kays, Helga Junker, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 508-508
Open Access | Times Cited: 9
Novel mobility index tracks COVID-19 transmission following stay-at-home orders
Peter Hyunwuk Her, Sahar Saeed, Khai Hoan Tram, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Modeling COVID-19 Disease with Deterministic and Data-Driven Models Using Daily Empirical Data in the United Kingdom
Janet O. Agbaje, Oluwatosin Babasola, Kabiru Michael Adeyemo, et al.
COVID (2024) Vol. 4, Iss. 2, pp. 289-316
Open Access | Times Cited: 1
Disparities and Outcomes in the First and Second Year of the Pandemic on Events of Acute Myocardial Infarction in Coronavirus Disease 2019 Patients
Jasninder Dhaliwal, Manraj Sekhon, Arush Rajotia, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 597-597
Open Access | Times Cited: 1
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination
Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, et al.
Human Antibodies (2024) Vol. 32, Iss. 3, pp. 85-106
Closed Access | Times Cited: 1
A cGAMP‐Containing Hydrogel for Prolonged SARS‐CoV‐2 Receptor‐Binding Domain Subunit Vaccine Exposure Induces a Broad and Potent Humoral Response
Volker Böhnert, Emily C. Gale, Lauren J. Lahey, et al.
Advanced NanoBiomed Research (2024)
Open Access | Times Cited: 1
The Delta Variant Triggers the Third Wave of COVID-19 in Mexico
Sergio Isaac De La Cruz Hernández, Gisela Barrera-Badillo
Disaster Medicine and Public Health Preparedness (2022) Vol. 16, Iss. 6, pp. 2225-2227
Open Access | Times Cited: 8
Lessons from SARS‑CoV‑2 and its variants (Review)
Ziwen Qin, Yan Sun, Jian Zhang, et al.
Molecular Medicine Reports (2022) Vol. 26, Iss. 2
Open Access | Times Cited: 8
Model-Based Evaluation of Transmissibility and Intervention Measures for a COVID-19 Outbreak in Xiamen City, China
Weikang Liu, Zhinan Guo, Buasiyamu Abudunaibi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 8
The impact of physical activity on well-being, lifestyle and health promotion in an era of COVID-19 and SARS-CoV-2 variant
Bohee So, Ki Han Kwon
Postgraduate Medicine (2022) Vol. 134, Iss. 4, pp. 349-358
Closed Access | Times Cited: 7
Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant
Tetsuya Akaishi, Shigeki Kushimoto, Yukio Katori, et al.
The Tohoku Journal of Experimental Medicine (2022) Vol. 257, Iss. 1, pp. 1-6
Open Access | Times Cited: 7
SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant
Makoto Sawano, Kyosuke Takeshita, Hideaki Ohno, et al.
Journal of Breath Research (2022) Vol. 16, Iss. 3, pp. 036006-036006
Open Access | Times Cited: 7
Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus
C. Almendarez-Rodríguez, Karla Ivón Solís-Andrade, Dania O. Govea‐Alonso, et al.
International Journal of Biological Macromolecules (2022) Vol. 213, pp. 1007-1017
Open Access | Times Cited: 7
Omicron Variant in Mexico: the Fourth COVID-19 Wave
Sergio Isaac De La Cruz Hernández, Ana Karen Álvarez-Contreras
Disaster Medicine and Public Health Preparedness (2022) Vol. 16, Iss. 6, pp. 2260-2261
Open Access | Times Cited: 7
The course of infection with the Delta variant of COVID-19 in pregnancy: analysis of clinical, laboratory, and neonatal outcomes
Mehmet Rıfat Göklü, Süleyman Cemil Oğlak, Zeynep Gedik Özköse, et al.
Journal of the Turkish-German Gynecological Association (2022) Vol. 24, Iss. 1, pp. 33-41
Open Access | Times Cited: 7

Scroll to top